Replimune REPL
NASDAQ REPL
$15.04 -0.25 (-1.64%)
As of: Sep 4, 2026 · 3:59 PM EDT

Replimune (REPL) Change in Acquisitions & Divestments (2018 - 2026)

Replimune (REPL) posted Change in Acquisitions & Divestments of $90.5 million for Q1 2026, down 11.11% sequentially from $101.8 million in Q4 2025, and up 39.03% YoY from $65.1 million in Q1 2025.

Analysis

Replimune (REPL) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends

Replimune has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $90.5 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 39.03% year-over-year to $90.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $393.0 million (up 1.68% YoY) and the FY2026 annual result came in at $393.0 million, up 1.68% from the prior year.
  • Change in Acquisitions & Divestments retreated to $90.5 million in Q1 2026 per REPL's latest filing, from $101.8 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $177.1 million in Q2 2023 and troughed at $60.0 million in Q1 2022.
  • A 5-year average of $110.3 million and a median of $105.4 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 164.39% in 2023, then tumbled 51.2% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $115.7 million in 2022, then surged by 34.46% to $155.5 million in 2023, then slumped by 40.53% to $92.5 million in 2024, then gained by 10.02% to $101.8 million in 2025, then dropped by 11.11% to $90.5 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $90.5 million, $101.8 million, and $95.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Replimune 1.46 Bn 1.46 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.88 Mn
Mar 31, 2026 90.46 Mn
Dec 31, 2025 101.77 Mn
Sep 30, 2025 95.36 Mn
Jun 30, 2025 105.37 Mn
Mar 31, 2025 65.07 Mn
Dec 31, 2024 92.50 Mn
Sep 30, 2024 92.00 Mn
Jun 30, 2024 136.91 Mn
Mar 31, 2024 133.34 Mn
Dec 31, 2023 155.54 Mn
Sep 30, 2023 126.35 Mn
Jun 30, 2023 177.14 Mn
Mar 31, 2023 127.00 Mn
Dec 31, 2022 115.68 Mn
Sep 30, 2022 133.50 Mn
Jun 30, 2022 67.00 Mn
Mar 31, 2022 60.00 Mn
Dec 31, 2021 68.24 Mn
Sep 30, 2021 68.50 Mn